Dupont De Nemours Inc (DD)

Sep 26, 2026

DuPont de Nemours, Inc. (NYSE:DD) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $166.60. Institutional ownership is high at 73.96%, and the company recently exceeded quarterly earnings and revenue estimates. Despite a strong performance, some analysts recommend looking at other stocks that may offer better buying opportunities.

Sep 25, 2026

Cape Fear River Watch and the Southeastern Environmental Law Center allege that Chemours has violated a 2019 consent order by continuing to discharge PFAS into groundwater and the Cape Fear River. Chemours denies these claims, asserting they have taken significant actions to mitigate pollution. The environmental groups are prepared to take legal action if the alleged violations are not remediated, while Chemours states the matter may become subject to legal proceedings.

Sep 25, 2026

The City of Birmingham has filed a federal lawsuit against 3M, DuPont-related companies, and over a dozen other manufacturers, alleging they sold firefighter gear containing harmful PFAS chemicals and concealed the risks for decades. The lawsuit, filed in U.S. District Court for the Northern District of Alabama, seeks to hold the companies accountable for the costs of testing, decontaminating, and replacing gear and equipment, as well as punitive and triple damages. This action follows a similar multi-state lawsuit and highlights a growing legal challenge against manufacturers over PFAS contamination in firefighter turnout gear.

Sep 24, 2026

Residents of Wood County have filed a proposed class-action lawsuit against Chemours, alleging that hazardous chemicals, including PFAS, released from the company's Washington Works plant landfill have contaminated their homes and land, causing property damage and health concerns. This new lawsuit follows previous settlements by Chemours regarding drinking water contamination and aims to provide direct benefits to the affected residents. The plaintiffs are seeking cleanup of the pollution, compensation for property damages, and continued medical monitoring.

Sep 24, 2026

Andra AP fonden significantly reduced its stake in DuPont de Nemours (NYSE:DD) by 57.7% in the second quarter, selling 23,771 shares but still holding 17,458 shares valued at approximately $2.37 million. Despite this, institutional ownership remains high at 73.96%, with other major investors like State Street Corp increasing their positions. Analysts maintain a "Moderate Buy" rating with an average price target of $166.60, and DuPont recently surpassed quarterly earnings expectations.

Sep 22, 2026

Nykredit A/S recently acquired 36,203 shares of DuPont de Nemours (NYSE:DD) valued at approximately $4.9 million during the second quarter. Institutional investors and hedge funds now collectively own 73.96% of the company. DuPont reported strong quarterly earnings of $1.88 per share, surpassing estimates, and analysts maintain a "Moderate Buy" rating with a consensus price target of $166.60.

Sep 21, 2026

North Carolina leaders are hailing a new $590 million settlement with Chemours, DuPont, and Corteva over PFAS contamination as historic. However, residents in affected areas like Cedar Creek and Gray’s Creek remain skeptical, questioning whether the deal will truly deliver reliable, safe drinking water to their homes. Many well owners distrust existing filtration systems and continue to rely on bottled water, emphasizing their desire for tangible action and long-term solutions.

Sep 19, 2026

Integrated Wealth Concepts LLC reduced its stake in DuPont de Nemours (NYSE:DD) by 65.3% in the second quarter, selling 13,713 shares and retaining 7,280 shares valued at $987,000. Despite this sale, institutional investors collectively own 73.96% of the company. Analysts hold a "Moderate Buy" consensus rating with an average price target of $166.60, following DuPont's strong Q2 earnings report where it beat EPS expectations and saw a 4% revenue increase.

Sep 19, 2026

Squarepoint Ops LLC significantly reduced its stake in DuPont de Nemours, Inc. (NYSE:DD) by 98.5% in the second quarter, selling 429,624 shares and retaining 6,498 shares. Despite this, institutional investors collectively own 73.96% of the company, and analysts maintain a "Moderate Buy" consensus rating with a target price of $166.60. DuPont also reported strong quarterly earnings, beating expectations, but its dividend yield of 1.9% is coupled with a high payout ratio of 533.33%.

Sep 17, 2026

DuPont (DD) stock is considered worth retaining due to its focus on innovation, productivity actions, and strategic acquisitions, despite facing headwinds from uneven construction demand and persistent cost pressures. The company's growth is driven by investments in high-growth areas like healthcare, water, aerospace, and EVs, along with cost synergy savings and an 80/20 program for efficiency. However, its Building Technologies business is exposed to a mixed construction market and higher input costs are impacting margins.

Sep 17, 2026

Corient Private Wealth LP significantly reduced its stake in DuPont de Nemours (NYSE:DD) by 66.8% in the second quarter of 2026, selling 151,831 shares and retaining 75,599 shares valued at approximately $10.25 million. Despite this, DuPont de Nemours reported strong quarterly earnings of $1.88 EPS, surpassing expectations, and analysts maintain a "Moderate Buy" rating with an average price target of $166.60. The company also announced a quarterly dividend of $0.60 per share.

Sep 16, 2026

Bladen County will receive $26.6 million over the next decade from a settlement with DuPont and Chemours related to PFAS pollution from the Fayetteville Works chemical plant. These funds are designated for water infrastructure projects, including replacing and installing new water lines, maintaining water towers, and expanding the county water system. This settlement is part of a larger $590 million agreement involving North Carolina and other affected local governments, aimed at addressing decades of environmental damage caused by "forever chemicals."

Sep 16, 2026

Chemours, DuPont, and Corteva have reached a $455 million settlement with North Carolina and 11 local entities concerning PFAS litigation related to the Fayetteville Works facility. The payment structure spans 15 years, with Chemours responsible for 50% of the settlement and expecting to pay approximately $50 million within the next year. This agreement also addresses off-site obligations, including drinking water programs, and recognizes progress made under a 2019 Consent Order.

Sep 16, 2026

Corteva recently held investor presentations for its seed business, Vylor, which is scheduled to spin off in early October, and for the remaining Corteva, which will operate as a crop protection pure-play company. These presentations provided insight into the growth strategies for both entities post-separation.

Sep 15, 2026

NewEdge Advisors LLC significantly reduced its stake in DuPont de Nemours, Inc. (NYSE:DD) by selling 68,142 shares, bringing its total holdings to 33,115 shares valued at $4.49 million. Other institutional investors also adjusted their positions, with overall institutional ownership standing at 73.96%. The article also details DuPont de Nemours' financial performance, dividend information, and recent analyst ratings.

Sep 14, 2026

Tidal Investments LLC significantly reduced its stake in DuPont de Nemours (NYSE:DD) by selling 53,359 shares, leaving them with 46,323 shares worth approximately $6.28 million. Despite this, institutional investors collectively own 73.96% of the company, and analysts generally maintain a "Moderate Buy" rating with an average price target of $166.60. DuPont also exceeded its recent quarterly earnings expectations, reporting $1.88 EPS against a $1.76 consensus.

Sep 14, 2026

Allworth Financial LP significantly reduced its stake in DuPont de Nemours, Inc. (NYSE:DD) by 68.6% in the second quarter, selling 12,708 shares to hold 5,820 shares valued at $789,000. Despite this, other institutional investors increased their positions in DD. The company has an average "Moderate Buy" rating from analysts with an average price target of $166.60 and recently announced a quarterly dividend of $0.60 per share.